Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: J Pain. 2023 Nov 22;25(3):742–754. doi: 10.1016/j.jpain.2023.10.003

Table 2:

Characteristics of Medicare beneficiaries with chronic low back pain in trajectory groups of physical therapy use

No or little PT use (Group 1) Delayed and increasing PT use (Group 2) Early and declining PT use (Group 3)
N=482,838 N=45,234 N=79,657
Age ≥65 years, % 339,445 (70.3) 36,582 (80.9) 68,593 (86.1)
Mean age (SD), years 67.6 (12.6) 69.6 (10.7) 70.8 (10.1)
Female sex, % 304,820 (63.1) 30,834 (68.2) 54,053 (67.9)
Race, %
 Non-Hispanic White 385,736 (79.9) 37,027 (81.9) 64,954 (81.5)
 Black or African-American 47,863 (9.9) 3,338 (7.4) 4,815 (6.0)
 Asian or Pacific Islander 9,730 (2.0) 1,258 (2.8) 3,469 (4.4)
 Hispanic (any race) 27,972 (5.8) 2,447 (5.4) 3,877 (4.9)
 American Indian or Alaska Native 3,274 (0.7) 199 (0.4) 264 (0.33)
 Other 2,752 (0.6) 303 (0.7) 721 (0.91)
 Unknown 5,511 (1.1) 662 (1.5) 1,557 (2.0)
Had low-income subsidy, % 193,160 (40.0) 11,646 (25.8) 17,872 (22.4)
Reason for current Medicare entitlement, %
 Old age and survivors insurance 339,448 (70.3) 36,583 (80.9) 68,593 (86.1)
 Disability insurance benefits 141,982 (29.4) 8,590 (19.0) 11,013 (13.8)
 End-stage renal disease 799 (0.2) 35 (0.1) 34 (0.04)
Had Dual Enrollment, % 175,607 (36.4) 10,845 (24.0) 16,608 (20.9)
U.S. Region, %
 Midwest 127,414 (26.4) 9,695 (21.4) 14,661 (18.4)
 Northeast 77,084 (16.0) 8,993 (19.9) 19,616 (24.6)
 South 198,950 (41.2) 15,898 (35.2) 24,401 (30.6)
 West 78,887 (16.3) 10,581 (23.4) 20,863 (26.2)
 Other 503 (0.1) 67 (0.2) 116 (0.15)
Metropolitan Status, %
 Metropolitan 353,005 (73.1) 37,208 (82.3) 67,693 (85.0)
 Rural 42,270 (8.8) 2,336 (5.2) 3,469 (4.35)
 Urban 87,361 (18.1) 5,656 (12.5) 8,416 (10.6)
Medical conditions diagnosed
 Opioid use disorder 45,257 (9.4) 2,981 (6.6) 3,405 (4.3)
 Non-back musculoskeletal pain 255,754 (53.0) 26,418 (58.4) 48,024 (60.3)
 Falls 27,588 (5.7) 2,463 (5.5) 5,006 (6.3)
 Fractures 21,336 (4.4) 2,060 (4.6) 4,452 (5.6)
 Surgeries 17,871 (3.7) 2,122 (4.7) 5,725 (7.2)
 Tobacco use disorder 43,755 (9.1) 2,382 (5.3) 3,000 (3.8)
 Alcohol use disorder 7,400 (1.5) 493 (1.1) 776 (1.0)
 Non-opioid drug use disorder 12,580 (2.6) 728 (1.6) 1,054 (1.3)
 Mental health disorder 156,082 (32.3) 13,350 (29.5) 21,022 (26.4)
 Diabetes (type 1 or 2) 137,362 (28.5) 12,106 (26.8) 20,797 (26.1)
 Cardiovascular disease 102,363 (21.2) 9,297 (20.6) 15,798 (19.83)
 Chronic obstructive pulmonary disease 79,932 (16.6) 5,828 (12.9) 87,34 (11.0)
 Asthma 41,787 (8.7) 4,326 (9.6) 7,163 (9.0)
 Hypertension 308,973 (64.0) 28,813 (63.7) 49,263 (61.8)
 Chronic kidney disease 54,688 (11.3) 4,671 (10.3) 7,628 (9.6)
 Drug overdose 3,463 (0.7) 238 (0.5) 330 (0.4)
 Dementia 12,775 (2.6) 827 (1.8) 1,633 (2.1)
Gagne comorbidity score
 <0 or 0 235,023 (48.7) 22,825 (50.4) 41,385 (52.0)
 1 98,686 (20.4) 9,486 (21.0) 16,491 (20.7)
 2 to 3 93,737 (19.4) 8,588 (19.0) 14,595 (18.3)
 4 or more 55,392 (11.5) 4,335 (9.6) 7,186 (9.0)
Died during follow-up, % 11,105 (2.3) 226 (0.5) 797 (1.0)

NOTE: PT = physical therapy, SD = standard deviation

Non-back musculoskeletal pain includes neck pain, fibromyalgia, and osteoarthritis; Non-opioid drug use disorder includes cannabis, sedative, cocaine and other use disorders; Mental health disorder includes schizophrenia, bipolar disorder, mood disorder, major depressive disorder, anxiety disorder, and psychotic disorder; Cardiovascular disease includes ischemic heart disease and heart failure

P-values for group comparisons were all <0.0001 except for falls (P=0.0041)